AIM
AGIO icon

AXA Investment Managers’s Agios Pharmaceuticals AGIO Stock Holding History

AXA Investment Managers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.13M Buy
+177,675
New +$6.68M 0.02% 485

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AXA Investment Managers's AGIO Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2025: 177,675 shares worth $7.13M. The stake represents 0.02% of the portfolio and ranks #485 among its holdings.

220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

  • AXA Investment Managers held 177,675 shares of Agios Pharmaceuticals worth $7.13M as of Q3 2025.
  • Agios Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Agios Pharmaceuticals made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #485 holding.
  • 220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.